What are the potential drug interactions between Augmentin (amoxicillin/clavulanic acid) and Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

No significant drug interactions exist between Augmentin (amoxicillin/clavulanic acid) and Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) that would prevent their concurrent use. These medications can generally be taken together without dose adjustments. Augmentin is primarily eliminated through the kidneys, while the components of Genvoya are metabolized through different pathways, mainly involving the liver. Cobicistat, a component of Genvoya, is a CYP3A4 inhibitor, but amoxicillin/clavulanic acid is not significantly affected by this pathway, as supported by a study on the pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination 1. Patients should still inform their healthcare providers about all medications they are taking, as individual factors may occasionally necessitate monitoring. Both medications can cause gastrointestinal side effects like diarrhea or nausea, so patients should be aware that these symptoms might be more pronounced when taking both medications. Maintaining adequate hydration is important while on these medications, particularly since both can affect kidney function in some patients, as noted in a review of the efficacy and safety of Genvoya 2. It is also worth considering the properties of oral amoxicillin and clavulanic acid, including their metabolism and potential for gastrointestinal side effects, as discussed in a narrative review 3. However, the most recent and highest quality study does not indicate any significant interactions between Augmentin and Genvoya that would impact their concurrent use 2. Key points to consider include:

  • The lack of significant drug interactions between Augmentin and Genvoya
  • The potential for gastrointestinal side effects when taking both medications
  • The importance of maintaining adequate hydration to minimize the risk of kidney function impairment
  • The need for patients to inform their healthcare providers about all medications they are taking to ensure safe and effective treatment.

References

Research

Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.